世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遺伝子治療薬の世界市場レポート2022年版


Global Gene Therapy Sales Market Report 2022

遺伝子治療は、病気と闘ったり予防したりするために、人の細胞に遺伝物質を導入する実験的治療法である。研究者たちは、重症複合免疫不全症、血友病、パーキンソン病、がん、さらにはHIVなど、多くの病気に対する... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年9月9日 US$4,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

遺伝子治療は、病気と闘ったり予防したりするために、人の細胞に遺伝物質を導入する実験的治療法である。研究者たちは、重症複合免疫不全症、血友病、パーキンソン病、がん、さらにはHIVなど、多くの病気に対する遺伝子治療を、さまざまなアプローチで研究している。遺伝子は、"ベクター "と呼ばれる運搬体を用いて細胞に送り込むことができる。遺伝子治療で使用されるベクターの最も一般的な種類はウイルスです。遺伝子治療に使用されるウイルスは、安全性を高めるために改変されていますが、それでも遺伝子治療にはリスクがあります。この技術はまだ初期段階にあります。

市場の分析と洞察遺伝子治療の世界市場
COVID-19の大流行により、遺伝子治療の世界市場規模は2021年に7077.6百万米ドルと推定され、レビュー期間中にCAGR27.6%で2028年までに7077.6百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮すると、2021年に遺伝子治療世界市場の%を占めたタイプ別は、2028年には百万米ドルの値を示し、COVID-19後の期間に修正された%のCAGRで成長すると予測されます。一方、タイプ別セグメントは、この予測期間を通して%CAGRに変更されています。
世界の遺伝子治療の主要企業は、バイオジェン、ノバルティス、ギリアド・サイエンシズなどです。世界の上位3社で約75%のシェアを占めています。
北米が最大の市場であり、そのシェアは約60%、次いで欧州とアジア太平洋地域がそれぞれ約35%を占めています。
製品別では、Non-viral Gene Therapyが最大のセグメントであり、約55%のシェアを占めています。また、アプリケーション別では、神経疾患が最も多く、次いでがんが多い。

遺伝子治療の世界市場範囲と市場規模
遺伝子治療の世界市場は、企業別、地域(国)別、タイプ別、用途別に分類されています。遺伝子治療の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント分析では、地域(国)別、タイプ別、アプリケーション別の売上、収益、2017-2028年までの予測に焦点を当てています。

タイプ別セグメント
ウイルス性遺伝子治療
非ウイルス性遺伝子治療

用途別セグメント
神経系疾患

その他

地域別
米国
欧州
中国
日本
東南アジア
インド
その他の地域

会社別
バイオジェン
ノバルティス
ギリアド・サイエンシズ
サレプタ・セラピューティック
アルニラム・ファーマシューティカルズ
アムジェン
スパーク・セラピューティック
アクセア・セラピューティック
ブルーバード・バイオ
サンウェイバイオテック
シビオノ
アンジェス
オーチャード・セラピューティック
ヒト幹細胞研究所


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size by Type (2017 VS 2021VS 2028)
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2017-2028)
2.2 Global Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.3 Global Gene Therapy Revenue Market Share by Region (2017-2022)
2.4 Global Gene Therapy Revenue Forecast by Region (2023-2028)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Gene Therapy Estimates and Projections (2017-2028)
2.5.2 Europe Gene Therapy Estimates and Projections (2017-2028)
2.5.3 China Gene Therapy Estimates and Projections (2017-2028)
2.5.4 Japan Gene Therapy Estimates and Projections (2017-2028)
2.5.5 Southeast Asia Gene Therapy Estimates and Projections (2017-2028)
2.5.6 India Gene Therapy Estimates and Projections (2017-2028)
3 Global Gene Therapy Competition Landscape by Players
3.1 Global Top Gene Therapy Players by Revenue (2017-2022)
3.1.1 Global Top Gene Therapy Players by Revenue (2017-2022)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2021
3.5 Gene Therapy Key Players Head office and Area Served
3.6 Key Players Gene Therapy Product Solution and Service
3.7 Date of Enter into Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2017-2022)
4.2 Global Gene Therapy Forecasted Market Size by Type (2023-2028)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2017-2022)
5.2 Global Gene Therapy Forecasted Market Size by Application (2023-2028)
6 United States Gene Therapy Market Facts & Figures
6.1 United States Gene Therapy Revenue by Company (2017-2022)
6.2 United States Gene Therapy Market Size by Type
6.2.1 United States Gene Therapy Market Size by Type (2017-2022)
6.2.2 United States Gene Therapy Market Size by Type (2023-2028)
6.2.3 United States Gene Therapy Market Share by Type (2017-2028)
6.3 United States Gene Therapy Market Size by Application
6.3.1 United States Gene Therapy Market Size by Application (2017-2022)
6.3.2 United States Gene Therapy Market Size by Application (2023-2028)
6.3.3 United States Gene Therapy Market Share by Application (2017-2028)
7 Europe Gene Therapy Market Facts & Figures
7.1 Europe Gene Therapy Revenue by Company (2017-2022)
7.2 Europe Gene Therapy Market Size by Type
7.2.1 Europe Gene Therapy Market Size by Type (2017-2022)
7.2.2 Europe Gene Therapy Market Size by Type (2023-2028)
7.2.3 Europe Gene Therapy Market Share by Type (2017-2028)
7.3 Europe Gene Therapy Market Size by Application
7.3.1 Europe Gene Therapy Market Size by Application (2017-2022)
7.3.2 Europe Gene Therapy Market Size by Application (2023-2028)
7.3.3 Europe Gene Therapy Market Share by Application (2017-2028)
8 China Gene Therapy Market Facts & Figures
8.1 China Gene Therapy Revenue by Company (2017-2022)
8.2 China Gene Therapy Market Size by Type
8.2.1 China Gene Therapy Market Size by Type (2017-2022)
8.2.2 China Gene Therapy Market Size by Type (2023-2028)
8.2.3 China Gene Therapy Market Share by Type (2017-2028)
8.3 China Gene Therapy Market Size by Application
8.3.1 China Gene Therapy Market Size by Application (2017-2022)
8.3.2 China Gene Therapy Market Size by Application (2023-2028)
8.3.3 China Gene Therapy Market Share by Application (2017-2028)
9 Japan Gene Therapy Market Facts & Figures
9.1 Japan Gene Therapy Revenue by Company (2017-2022)
9.2 Japan Gene Therapy Market Size by Type
9.2.1 Japan Gene Therapy Market Size by Type (2017-2022)
9.2.2 Japan Gene Therapy Market Size by Type (2023-2028)
9.2.3 Japan Gene Therapy Market Share by Type (2017-2028)
9.3 Japan Gene Therapy Market Size by Application
9.3.1 Japan Gene Therapy Market Size by Application (2017-2022)
9.3.2 Japan Gene Therapy Market Size by Application (2023-2028)
9.3.3 Japan Gene Therapy Market Share by Application (2017-2028)
10 Southeast Asia Gene Therapy Market Facts & Figures
10.1 Southeast Asia Gene Therapy Revenue by Company (2017-2022)
10.2 Southeast Asia Gene Therapy Market Size by Type
10.2.1 Southeast Asia Gene Therapy Market Size by Type (2017-2022)
10.2.2 Southeast Asia Gene Therapy Market Size by Type (2023-2028)
10.2.3 Southeast Asia Gene Therapy Market Share by Type (2017-2028)
10.3 Southeast Asia Gene Therapy Market Size by Application
10.3.1 Southeast Asia Gene Therapy Market Size by Application (2017-2022)
10.3.2 Southeast Asia Gene Therapy Market Size by Application (2023-2028)
10.3.3 Southeast Asia Gene Therapy Market Share by Application (2017-2028)
11 India Gene Therapy Market Facts & Figures
11.1 India Gene Therapy Revenue by Company (2017-2022)
11.2 India Gene Therapy Market Size by Type
11.2.1 India Gene Therapy Market Size by Type (2017-2022)
11.2.2 India Gene Therapy Market Size by Type (2023-2028)
11.2.3 India Gene Therapy Market Share by Type (2017-2028)
11.3 India Gene Therapy Market Size by Application
11.3.1 India Gene Therapy Market Size by Application (2017-2022)
11.3.2 India Gene Therapy Market Size by Application (2023-2028)
11.3.3 India Gene Therapy Market Share by Application (2017-2028)
12 Key Players Profiles
12.1 Biogen
12.1.1 Biogen Company Details
12.1.2 Biogen Business Overview
12.1.3 Biogen Gene Therapy Introduction
12.1.4 Biogen Revenue in Gene Therapy Business (2017-2022)
12.1.5 Biogen Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Novartis Business Overview
12.2.3 Novartis Gene Therapy Introduction
12.2.4 Novartis Revenue in Gene Therapy Business (2017-2022)
12.2.5 Novartis Recent Development
12.3 Gilead Sciences
12.3.1 Gilead Sciences Company Details
12.3.2 Gilead Sciences Business Overview
12.3.3 Gilead Sciences Gene Therapy Introduction
12.3.4 Gilead Sciences Revenue in Gene Therapy Business (2017-2022)
12.3.5 Gilead Sciences Recent Development
12.4 Sarepta Therapeutics
12.4.1 Sarepta Therapeutics Company Details
12.4.2 Sarepta Therapeutics Business Overview
12.4.3 Sarepta Therapeutics Gene Therapy Introduction
12.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.4.5 Sarepta Therapeutics Recent Development
12.5 Alnylam Pharmaceuticals
12.5.1 Alnylam Pharmaceuticals Company Details
12.5.2 Alnylam Pharmaceuticals Business Overview
12.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
12.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2017-2022)
12.5.5 Alnylam Pharmaceuticals Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Amgen Business Overview
12.6.3 Amgen Gene Therapy Introduction
12.6.4 Amgen Revenue in Gene Therapy Business (2017-2022)
12.6.5 Amgen Recent Development
12.7 Spark Therapeutics
12.7.1 Spark Therapeutics Company Details
12.7.2 Spark Therapeutics Business Overview
12.7.3 Spark Therapeutics Gene Therapy Introduction
12.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.7.5 Spark Therapeutics Recent Development
12.8 Akcea Therapeutics
12.8.1 Akcea Therapeutics Company Details
12.8.2 Akcea Therapeutics Business Overview
12.8.3 Akcea Therapeutics Gene Therapy Introduction
12.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.8.5 Akcea Therapeutics Recent Development
12.9 bluebird bio
12.9.1 bluebird bio Company Details
12.9.2 bluebird bio Business Overview
12.9.3 bluebird bio Gene Therapy Introduction
12.9.4 bluebird bio Revenue in Gene Therapy Business (2017-2022)
12.9.5 bluebird bio Recent Development
12.10 Sunway Biotech
12.10.1 Sunway Biotech Company Details
12.10.2 Sunway Biotech Business Overview
12.10.3 Sunway Biotech Gene Therapy Introduction
12.10.4 Sunway Biotech Revenue in Gene Therapy Business (2017-2022)
12.10.5 Sunway Biotech Recent Development
12.11 SIBIONO
12.11.1 SIBIONO Company Details
12.11.2 SIBIONO Business Overview
12.11.3 SIBIONO Gene Therapy Introduction
12.11.4 SIBIONO Revenue in Gene Therapy Business (2017-2022)
12.11.5 SIBIONO Recent Development
12.12 AnGes
12.12.1 AnGes Company Details
12.12.2 AnGes Business Overview
12.12.3 AnGes Gene Therapy Introduction
12.12.4 AnGes Revenue in Gene Therapy Business (2017-2022)
12.12.5 AnGes Recent Development
12.13 Orchard Therapeutics
12.13.1 Orchard Therapeutics Company Details
12.13.2 Orchard Therapeutics Business Overview
12.13.3 Orchard Therapeutics Gene Therapy Introduction
12.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.13.5 Orchard Therapeutics Recent Development
12.14 Human Stem Cells Institute
12.14.1 Human Stem Cells Institute Company Details
12.14.2 Human Stem Cells Institute Business Overview
12.14.3 Human Stem Cells Institute Gene Therapy Introduction
12.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2017-2022)
12.14.5 Human Stem Cells Institute Recent Development
13 Market Dynamics
13.1 Gene Therapy Industry Trends
13.2 Gene Therapy Market Drivers
13.3 Gene Therapy Market Challenges
13.4 Gene Therapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Market Analysis and Insights: Global Gene Therapy Market
Due to the COVID-19 pandemic, the global Gene Therapy market size is estimated to be worth US$ 7077.6 million in 2021 and is forecast to a readjusted size of US$ 7077.6 million by 2028 with a CAGR of 27.6% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Gene Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

Global Gene Therapy Scope and Market Size
The global Gene Therapy market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy

Segment by Application
Neurological Diseases
Cancer
Other

By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions

By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size by Type (2017 VS 2021VS 2028)
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2017-2028)
2.2 Global Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.3 Global Gene Therapy Revenue Market Share by Region (2017-2022)
2.4 Global Gene Therapy Revenue Forecast by Region (2023-2028)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Gene Therapy Estimates and Projections (2017-2028)
2.5.2 Europe Gene Therapy Estimates and Projections (2017-2028)
2.5.3 China Gene Therapy Estimates and Projections (2017-2028)
2.5.4 Japan Gene Therapy Estimates and Projections (2017-2028)
2.5.5 Southeast Asia Gene Therapy Estimates and Projections (2017-2028)
2.5.6 India Gene Therapy Estimates and Projections (2017-2028)
3 Global Gene Therapy Competition Landscape by Players
3.1 Global Top Gene Therapy Players by Revenue (2017-2022)
3.1.1 Global Top Gene Therapy Players by Revenue (2017-2022)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2021
3.5 Gene Therapy Key Players Head office and Area Served
3.6 Key Players Gene Therapy Product Solution and Service
3.7 Date of Enter into Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2017-2022)
4.2 Global Gene Therapy Forecasted Market Size by Type (2023-2028)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2017-2022)
5.2 Global Gene Therapy Forecasted Market Size by Application (2023-2028)
6 United States Gene Therapy Market Facts & Figures
6.1 United States Gene Therapy Revenue by Company (2017-2022)
6.2 United States Gene Therapy Market Size by Type
6.2.1 United States Gene Therapy Market Size by Type (2017-2022)
6.2.2 United States Gene Therapy Market Size by Type (2023-2028)
6.2.3 United States Gene Therapy Market Share by Type (2017-2028)
6.3 United States Gene Therapy Market Size by Application
6.3.1 United States Gene Therapy Market Size by Application (2017-2022)
6.3.2 United States Gene Therapy Market Size by Application (2023-2028)
6.3.3 United States Gene Therapy Market Share by Application (2017-2028)
7 Europe Gene Therapy Market Facts & Figures
7.1 Europe Gene Therapy Revenue by Company (2017-2022)
7.2 Europe Gene Therapy Market Size by Type
7.2.1 Europe Gene Therapy Market Size by Type (2017-2022)
7.2.2 Europe Gene Therapy Market Size by Type (2023-2028)
7.2.3 Europe Gene Therapy Market Share by Type (2017-2028)
7.3 Europe Gene Therapy Market Size by Application
7.3.1 Europe Gene Therapy Market Size by Application (2017-2022)
7.3.2 Europe Gene Therapy Market Size by Application (2023-2028)
7.3.3 Europe Gene Therapy Market Share by Application (2017-2028)
8 China Gene Therapy Market Facts & Figures
8.1 China Gene Therapy Revenue by Company (2017-2022)
8.2 China Gene Therapy Market Size by Type
8.2.1 China Gene Therapy Market Size by Type (2017-2022)
8.2.2 China Gene Therapy Market Size by Type (2023-2028)
8.2.3 China Gene Therapy Market Share by Type (2017-2028)
8.3 China Gene Therapy Market Size by Application
8.3.1 China Gene Therapy Market Size by Application (2017-2022)
8.3.2 China Gene Therapy Market Size by Application (2023-2028)
8.3.3 China Gene Therapy Market Share by Application (2017-2028)
9 Japan Gene Therapy Market Facts & Figures
9.1 Japan Gene Therapy Revenue by Company (2017-2022)
9.2 Japan Gene Therapy Market Size by Type
9.2.1 Japan Gene Therapy Market Size by Type (2017-2022)
9.2.2 Japan Gene Therapy Market Size by Type (2023-2028)
9.2.3 Japan Gene Therapy Market Share by Type (2017-2028)
9.3 Japan Gene Therapy Market Size by Application
9.3.1 Japan Gene Therapy Market Size by Application (2017-2022)
9.3.2 Japan Gene Therapy Market Size by Application (2023-2028)
9.3.3 Japan Gene Therapy Market Share by Application (2017-2028)
10 Southeast Asia Gene Therapy Market Facts & Figures
10.1 Southeast Asia Gene Therapy Revenue by Company (2017-2022)
10.2 Southeast Asia Gene Therapy Market Size by Type
10.2.1 Southeast Asia Gene Therapy Market Size by Type (2017-2022)
10.2.2 Southeast Asia Gene Therapy Market Size by Type (2023-2028)
10.2.3 Southeast Asia Gene Therapy Market Share by Type (2017-2028)
10.3 Southeast Asia Gene Therapy Market Size by Application
10.3.1 Southeast Asia Gene Therapy Market Size by Application (2017-2022)
10.3.2 Southeast Asia Gene Therapy Market Size by Application (2023-2028)
10.3.3 Southeast Asia Gene Therapy Market Share by Application (2017-2028)
11 India Gene Therapy Market Facts & Figures
11.1 India Gene Therapy Revenue by Company (2017-2022)
11.2 India Gene Therapy Market Size by Type
11.2.1 India Gene Therapy Market Size by Type (2017-2022)
11.2.2 India Gene Therapy Market Size by Type (2023-2028)
11.2.3 India Gene Therapy Market Share by Type (2017-2028)
11.3 India Gene Therapy Market Size by Application
11.3.1 India Gene Therapy Market Size by Application (2017-2022)
11.3.2 India Gene Therapy Market Size by Application (2023-2028)
11.3.3 India Gene Therapy Market Share by Application (2017-2028)
12 Key Players Profiles
12.1 Biogen
12.1.1 Biogen Company Details
12.1.2 Biogen Business Overview
12.1.3 Biogen Gene Therapy Introduction
12.1.4 Biogen Revenue in Gene Therapy Business (2017-2022)
12.1.5 Biogen Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Novartis Business Overview
12.2.3 Novartis Gene Therapy Introduction
12.2.4 Novartis Revenue in Gene Therapy Business (2017-2022)
12.2.5 Novartis Recent Development
12.3 Gilead Sciences
12.3.1 Gilead Sciences Company Details
12.3.2 Gilead Sciences Business Overview
12.3.3 Gilead Sciences Gene Therapy Introduction
12.3.4 Gilead Sciences Revenue in Gene Therapy Business (2017-2022)
12.3.5 Gilead Sciences Recent Development
12.4 Sarepta Therapeutics
12.4.1 Sarepta Therapeutics Company Details
12.4.2 Sarepta Therapeutics Business Overview
12.4.3 Sarepta Therapeutics Gene Therapy Introduction
12.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.4.5 Sarepta Therapeutics Recent Development
12.5 Alnylam Pharmaceuticals
12.5.1 Alnylam Pharmaceuticals Company Details
12.5.2 Alnylam Pharmaceuticals Business Overview
12.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
12.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2017-2022)
12.5.5 Alnylam Pharmaceuticals Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Amgen Business Overview
12.6.3 Amgen Gene Therapy Introduction
12.6.4 Amgen Revenue in Gene Therapy Business (2017-2022)
12.6.5 Amgen Recent Development
12.7 Spark Therapeutics
12.7.1 Spark Therapeutics Company Details
12.7.2 Spark Therapeutics Business Overview
12.7.3 Spark Therapeutics Gene Therapy Introduction
12.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.7.5 Spark Therapeutics Recent Development
12.8 Akcea Therapeutics
12.8.1 Akcea Therapeutics Company Details
12.8.2 Akcea Therapeutics Business Overview
12.8.3 Akcea Therapeutics Gene Therapy Introduction
12.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.8.5 Akcea Therapeutics Recent Development
12.9 bluebird bio
12.9.1 bluebird bio Company Details
12.9.2 bluebird bio Business Overview
12.9.3 bluebird bio Gene Therapy Introduction
12.9.4 bluebird bio Revenue in Gene Therapy Business (2017-2022)
12.9.5 bluebird bio Recent Development
12.10 Sunway Biotech
12.10.1 Sunway Biotech Company Details
12.10.2 Sunway Biotech Business Overview
12.10.3 Sunway Biotech Gene Therapy Introduction
12.10.4 Sunway Biotech Revenue in Gene Therapy Business (2017-2022)
12.10.5 Sunway Biotech Recent Development
12.11 SIBIONO
12.11.1 SIBIONO Company Details
12.11.2 SIBIONO Business Overview
12.11.3 SIBIONO Gene Therapy Introduction
12.11.4 SIBIONO Revenue in Gene Therapy Business (2017-2022)
12.11.5 SIBIONO Recent Development
12.12 AnGes
12.12.1 AnGes Company Details
12.12.2 AnGes Business Overview
12.12.3 AnGes Gene Therapy Introduction
12.12.4 AnGes Revenue in Gene Therapy Business (2017-2022)
12.12.5 AnGes Recent Development
12.13 Orchard Therapeutics
12.13.1 Orchard Therapeutics Company Details
12.13.2 Orchard Therapeutics Business Overview
12.13.3 Orchard Therapeutics Gene Therapy Introduction
12.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2017-2022)
12.13.5 Orchard Therapeutics Recent Development
12.14 Human Stem Cells Institute
12.14.1 Human Stem Cells Institute Company Details
12.14.2 Human Stem Cells Institute Business Overview
12.14.3 Human Stem Cells Institute Gene Therapy Introduction
12.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2017-2022)
12.14.5 Human Stem Cells Institute Recent Development
13 Market Dynamics
13.1 Gene Therapy Industry Trends
13.2 Gene Therapy Market Drivers
13.3 Gene Therapy Market Challenges
13.4 Gene Therapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療IT)の最新刊レポート

本レポートと同じKEY WORD(gene)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る